Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Orchestra BioMed Holdings, Inc. (OBIO) is a Biotechnology company based in US with a market capitalization of $221M. Revenue grew 1169.2% year-over-year and free cash flow was negative at -$49.5M. This page tracks OBIO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 70 employees · IPO Aug 4, 2020
Valuation
Valuation & price
$3.82as of Jul 14, 2026· -28.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
3.49
P/B ratio
Market cap ÷ book equity
No dividend
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$221M
Market cap
1169.2%
Revenue growth (YoY)
99.4%
Gross margin
-$49.5M
Free cash flow (USD)
-$104.8M
Net debt
Net cash position
4.3%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2020 → 2025
Free cash flow by year
2020 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
5
Insider buys · 90 days
2
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 12, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJun 23, 2026Filing
Annual Meeting Results
- Insider sellJun 2, 2026Filing
Insider Sell $58K · 10b5-1 PlanSherman Darren · Director, See Remarks · $58.1K
- Insider buyJun 2, 2026Filing
Insider Buy $19KHochman David P · Director, See Remarks · $19.2K
- Insider buyMay 20, 2026Filing
Insider Buy $2KAryeh Jason · Director · $2.5K
- Insider buyMay 19, 2026Filing
Insider Buy $19KHochman David P · Director, See Remarks · $18.9K
- Insider buyMay 19, 2026Filing
Insider Buy $35KAryeh Jason · Director · $35K
- Insider buyMay 18, 2026Filing
Insider Buy $83KFain Eric S · Director · $82.6K
- Quarterly reportMay 12, 2026Filing
10-Q Filed
- Insider sellApr 29, 2026Filing
Insider Sell $132RTW INVESTMENTS, LP · 10% Owner · $132.2
Questions
Frequently asked questions
What is Orchestra BioMed Holdings, Inc.'s market cap?
Orchestra BioMed Holdings, Inc. (OBIO) has a market capitalization of $221M.
What is OBIO's P/E ratio?
A meaningful P/E ratio is not available for OBIO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is OBIO's price-to-book (P/B) ratio?
OBIO trades at 3.49 times book value per share.
Does Orchestra BioMed Holdings, Inc. pay a dividend?
No — OBIO did not pay a dividend in its latest reported fiscal year.
Are insiders buying OBIO stock?
Yes — SEC Form 4 filings show 5 open-market insider buys and 2 sells at Orchestra BioMed Holdings, Inc. in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.